Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.2, 2005-01, pp. : 169-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sivelestat cost saving for acute lung injury in Japan

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Sivelestat cost saving for acute lung injury in Japan

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost‐Minimisation Analysis of Midazolam versus Droperidol for Acute Agitation in the Emergency Department

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 1, 2012-03 ,pp. : 11-16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome

By Angelo J.D.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 19-29

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel interaction: Interaction with concomitant atorvastatin leading to liver injury and systemic inflammatory response syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite